isoniazid has been researched along with 3-aminopyridine-2-carboxaldehyde thiosemicarbazone in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chaston, TB; Lovejoy, DB; Richardson, DR; Watts, RN | 1 |
Kalinowski, DS; Richardson, DR | 1 |
2 other study(ies) available for isoniazid and 3-aminopyridine-2-carboxaldehyde thiosemicarbazone
Article | Year |
---|---|
Examination of the antiproliferative activity of iron chelators: multiple cellular targets and the different mechanism of action of triapine compared with desferrioxamine and the potent pyridoxal isonicotinoyl hydrazone analogue 311.
Topics: Animals; Ascorbic Acid; Blotting, Northern; Blotting, Western; Cell Division; Chelating Agents; Deferoxamine; DNA; Dose-Response Relationship, Drug; Electron Spin Resonance Spectroscopy; Free Radicals; Glutathione; Humans; Iron; Iron Chelating Agents; Isoniazid; Models, Chemical; Oxidation-Reduction; Oxygen; Plasmids; Protein Binding; Pyridines; Rats; Thiosemicarbazones; Time Factors; Tumor Cells, Cultured | 2003 |
Future of toxicology--iron chelators and differing modes of action and toxicity: the changing face of iron chelation therapy.
Topics: Chelation Therapy; Humans; Hydrazones; Iron Chelating Agents; Iron Overload; Isoniazid; Pyridines; Pyridoxal; Structure-Activity Relationship; Thiosemicarbazones; Toxicology | 2007 |